Lantern Pharma Inc.(LTRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LTRN Lantern Pharma Inc.

未开盘 01-12 16:00:00 EST

3.36

-0.13

-3.72%

盘后3.36

+0.000.00%

16:10 EST

最高3.48	最低3.30	成交量5.22万
今开3.46	昨收3.49	日振幅5.04%
总市值3,758万	流通市值2,885万	总股本1,118万
成交额17.51万	换手率0.61%	流通股本858.74万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LTRN","market":"US","secType":"STK","nameCN":"Lantern Pharma Inc.","latestPrice":3.36,"timestamp":1768251600000,"preClose":3.49,"halted":0,"volume":52243,"hourTrading":{"tag":"盘后","latestPrice":3.36,"preClose":3.36,"latestTime":"16:10 EST","volume":6,"amount":20.16,"timestamp":1768252204215},"delay":0,"floatShares":8587400,"shares":11184423,"eps":-1.752393,"marketStatus":"未开盘","change":-0.13,"latestTime":"01-12 16:00:00 EST","open":3.46,"high":3.476,"low":3.3,"amount":175075.477319,"amplitude":0.05043,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.752393,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768294800000},"marketStatusCode":0,"adr":0,"listingDate":1591848000000,"exchange":"NASDAQ","adjPreClose":3.49,"preHourTrading":{"tag":"盘前","latestPrice":3.56,"preClose":3.49,"latestTime":"09:25 EST","volume":550,"amount":1962.99994,"timestamp":1768227931726},"postHourTrading":{"tag":"盘后","latestPrice":3.36,"preClose":3.36,"latestTime":"16:10 EST","volume":6,"amount":20.16,"timestamp":1768252204215},"volumeRatio":1.104139,"impliedVol":0.7865,"impliedVolPercentile":0.51},"requestUrl":"/m/hq/s/LTRN","defaultTab":"news","newsList":[{"id":"1147964916","title":"Lantern Pharma Inc.：临床试验达到所有主要安全性和耐受性终点，并确立明确的推荐二期剂量","url":"https://stock-news.laohu8.com/highlight/detail?id=1147964916","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147964916?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:42","pubTimestamp":1764769338,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc.：临床试验达到所有主要安全性和耐受性终点，并确立明确的推荐二期剂量","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"1112567254","title":"Lantern Pharma发布Lp-184一期a阶段的积极结果，显示在重度治疗的晚期癌症患者中具备持久的疾病控制","url":"https://stock-news.laohu8.com/highlight/detail?id=1112567254","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112567254?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:37","pubTimestamp":1764769035,"startTime":"0","endTime":"0","summary":"Lantern Pharma发布Lp-184一期a阶段的积极结果，显示在重度治疗的晚期癌症患者中具备持久的疾病控制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2584490312","title":"Lantern Pharma Inc.盘中异动 股价大涨6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584490312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584490312?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:35","pubTimestamp":1763562952,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日22时35分，Lantern Pharma Inc.股票出现异动，股价急速拉升6.24%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Kazia Therapeutics Limited、Biovie Inc C/Wts 08/08/2030、Fulcrum Therapeutics, Inc.涨幅较大，Kazia Therapeutics Limited、Clearmind Medicine Inc.、Can Fite Biopharma Ltd较为活跃，换手率分别为882.78%、81.23%、24.69%，振幅较大的相关个股有Kazia Therapeutics Limited、Fulcrum Therapeutics, Inc.、Annexon, Inc.，振幅分别为13.89%、13.79%、11.41%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119223552a7049b99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119223552a7049b99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"1196720567","title":"Lantern Pharma在第25届LL&M大会上展示Lp-284临床数据，突显在疗法已耗竭的DLBCL患者中取得的完全反应及其在晚期B细胞癌症中的治疗潜力。","url":"https://stock-news.laohu8.com/highlight/detail?id=1196720567","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196720567?lang=zh_cn&edition=full","pubTime":"2025-10-28 20:49","pubTimestamp":1761655763,"startTime":"0","endTime":"0","summary":"Lantern Pharma在第25届LL&M大会上展示Lp-284临床数据，突显在疗法已耗竭的DLBCL患者中取得的完全反应及其在晚期B细胞癌症中的治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2575765372","title":"Lantern Pharma Inc.盘中异动 股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575765372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575765372?lang=zh_cn&edition=full","pubTime":"2025-10-14 21:38","pubTimestamp":1760449125,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日21时38分，Lantern Pharma Inc.股票出现异动，股价快速下挫5.78%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为2015.20%、20.17%、17.21%，振幅较大的相关个股有Genprex, Inc.、Osr Holdings, Inc.、Pmgc Holdings Inc.，振幅分别为25.72%、17.22%、16.31%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213846972d9b79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014213846972d9b79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2570750037","title":"Lantern Pharma Inc.盘中异动 股价大涨7.12%报4.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570750037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570750037?lang=zh_cn&edition=full","pubTime":"2025-09-24 22:06","pubTimestamp":1758722771,"startTime":"0","endTime":"0","summary":"北京时间2025年09月24日22时06分，Lantern Pharma Inc.股票出现波动，股价快速上涨7.12%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Uniqure N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tnf Pharmaceuticals, Inc.涨幅较大，Tnf Pharmaceuticals, Inc.、Cyclerion Therapeutics, Inc.、Uniqure N.V.较为活跃，换手率分别为693.02%、373.23%、42.48%，振幅较大的相关个股有Tnf Pharmaceuticals, Inc.、Uniqure N.V.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为55.27%、40.92%、30.63%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092422061197a72de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092422061197a72de0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"1100777157","title":"Lantern Pharma公司Lp-184药物1a期临床试验达成所有主要终点，在多种晚期实体瘤治疗中展现稳健安全性和良好抗肿瘤活性","url":"https://stock-news.laohu8.com/highlight/detail?id=1100777157","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100777157?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:29","pubTimestamp":1758025761,"startTime":"0","endTime":"0","summary":"Lantern Pharma公司的Lp-184药物1a期临床试验成功达成所有主要研究终点，该试验显示出稳健的安全性特征，并在多种晚期实体瘤的治疗中展现出令人鼓舞的抗肿瘤活性。\n这项临床试验的积极结果为Lp-184药物的进一步开发奠定了坚实基础，同时也为晚期实体瘤患者带来了新的治疗希望。试验数据表明，该药物在安全性方面表现良好，为后续临床研究的推进提供了有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"1176375292","title":"Ibn宣布推出最新一期Biomedwire播客，邀请专注疑难和罕见癌症AI驱动生物技术公司Lantern Pharma Inc. (LTRN) 首席执行官Panna Sharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1176375292","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176375292?lang=zh_cn&edition=full","pubTime":"2025-09-10 20:01","pubTimestamp":1757505688,"startTime":"0","endTime":"0","summary":"Ibn公司近日宣布推出最新一期Biomedwire播客节目，本期节目邀请到了Lantern Pharma Inc. (LTRN)的首席执行官Panna Sharma作为嘉宾。Lantern Pharma Inc.是一家运用人工智能技术驱动的生物技术公司，专门致力于攻克疑难和罕见癌症治疗领域的挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"1135349447","title":"Lantern Pharma Inc计划在2026年第一季度提交IND修正案并启动小儿中枢神经系统癌症试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1135349447","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135349447?lang=zh_cn&edition=full","pubTime":"2025-09-03 21:48","pubTimestamp":1756907299,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc计划在2026年第一季度提交IND修正案并启动小儿中枢神经系统癌症试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"1184065430","title":"Lantern Pharma Inc - FDA确认螺内酯有望在试验中作为联合药物使用","url":"https://stock-news.laohu8.com/highlight/detail?id=1184065430","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184065430?lang=zh_cn&edition=full","pubTime":"2025-09-03 21:47","pubTimestamp":1756907235,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc - FDA确认螺内酯有望在试验中作为联合药物使用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"1147304963","title":"Lantern Pharma Inc.宣布与FDA完成C类会议，为儿科中枢神经系统癌症试验的监管路径提供明确指导","url":"https://stock-news.laohu8.com/highlight/detail?id=1147304963","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147304963?lang=zh_cn&edition=full","pubTime":"2025-09-03 21:44","pubTimestamp":1756907060,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc.宣布与FDA完成C类会议，为儿科中枢神经系统癌症试验的监管路径提供明确指导","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2562799061","title":"Lantern Pharma Inc.盘中异动 急速下挫5.69%报4.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562799061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562799061?lang=zh_cn&edition=full","pubTime":"2025-08-27 03:05","pubTimestamp":1756235159,"startTime":"0","endTime":"0","summary":"北京时间2025年08月27日03时05分，Lantern Pharma Inc.股票出现波动，股价大幅下跌5.69%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Invivyd, Inc.、Allarity Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Allarity Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Virax Biolabs Group Limited较为活跃，换手率分别为2513.05%、1264.15%、541.86%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Moolec Science Sa C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为87.11%、86.26%、83.33%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508270305599762ee66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508270305599762ee66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2558616536","title":"Lantern Pharma Inc.盘中异动 早盘股价大跌5.01%报4.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558616536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558616536?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:21","pubTimestamp":1754925694,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时21分，Lantern Pharma Inc.股票出现波动，股价大幅下挫5.01%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5542.09%、487.84%、168.13%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232135a6dfdfed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811232135a6dfdfed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2557628765","title":"Lantern Pharma Inc.盘中异动 早盘快速下挫5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557628765","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557628765?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:11","pubTimestamp":1754575863,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日22时11分，Lantern Pharma Inc.股票出现波动，股价快速下挫5.64%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1507.53%、106.52%、78.10%，振幅较大的相关个股有Palisade Bio, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Briacell Therapeutics Corp C/Wts ，振幅分别为72.00%、39.49%、23.01%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722110394d5afa3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080722110394d5afa3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2557230853","title":"Lantern Pharma Inc.盘中异动 早盘股价大涨7.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557230853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557230853?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:32","pubTimestamp":1754487154,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时32分，Lantern Pharma Inc.股票出现异动，股价快速拉升7.15%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.12%。其相关个股中，Biomx Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Adaptive Biotechnologies Corporation涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为325.63%、276.86%、14.14%，振幅较大的相关个股有Fortrea Holdings Inc.、Biomx Inc.、Fractyl Health, Inc.，振幅分别为18.14%、13.47%、8.82%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213235a6d6b37a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213235a6d6b37a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2556481120","title":"Lantern Pharma Inc.盘中异动 大幅跳水6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556481120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556481120?lang=zh_cn&edition=full","pubTime":"2025-08-01 21:55","pubTimestamp":1754056501,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日21时55分，Lantern Pharma Inc.股票出现异动，股价急速跳水6.53%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Bioxcel Therapeutics, Inc.、天境生物涨幅较大，Bioxcel Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为977.76%、123.84%、119.96%，振幅较大的相关个股有Neurosense Therapeutics Ltd.、天境生物、Bioxcel Therapeutics, Inc.，振幅分别为36.34%、22.89%、22.14%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801215502972d0a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801215502972d0a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2555383954","title":"Lantern Pharma Inc.盘中异动 股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555383954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555383954?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:35","pubTimestamp":1753968905,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时35分，Lantern Pharma Inc.股票出现波动，股价大幅上涨5.70%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为2.45%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Psyence Biomedical Ltd.、Soligenix, Inc.较为活跃，换手率分别为3670.53%、1939.12%、1799.57%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Soligenix, Inc.，振幅分别为32.00%、19.92%、18.40%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213505a6cbcb70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213505a6cbcb70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2554708850","title":"Lantern Pharma Inc.盘中异动 急速跳水5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554708850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554708850?lang=zh_cn&edition=full","pubTime":"2025-07-28 23:13","pubTimestamp":1753715590,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日23时13分，Lantern Pharma Inc.股票出现波动，股价大幅跳水5.67%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Abpro Holdings, Inc涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为423.82%、207.40%、120.74%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为125.48%、82.93%、75.48%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823131097237165&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072823131097237165&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"gpt_icon":0},{"id":"2518789671","title":"Lantern Pharma Inc.盘中异动 下午盘股价大跌5.46%报3.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518789671?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:09","pubTimestamp":1741633784,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时09分，Lantern Pharma Inc.股票出现波动，股价急速下跌5.46%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6241.48%、3860.05%、1021.55%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030944abf37882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030944abf37882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"gpt_icon":0},{"id":"2516776966","title":"Lantern Pharma Inc.盘中异动 股价大跌5.39%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516776966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516776966?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:41","pubTimestamp":1741099305,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时41分，Lantern Pharma Inc.股票出现波动，股价急速下挫5.39%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1118.41%、1103.36%、453.16%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为37.67%、22.25%、21.85%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224145963947cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224145963947cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lanternpharma.com","stockEarnings":[{"period":"1week","weight":0.0338},{"period":"1month","weight":-0.0667},{"period":"3month","weight":-0.2311},{"period":"6month","weight":-0.1579},{"period":"1year","weight":-0.1362},{"period":"ytd","weight":0.1089}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lantern Pharma Inc.成立于2013年11月7日。该公司是一家临床阶段生物技术公司，致力于利用人工智能（“A.I.”），机器学习和基因组数据来简化药物开发流程并使将要治疗的患者能从其靶向肿瘤治疗中受益。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.042903},{"month":2,"riseRate":0.4,"avgChangeRate":-0.00833},{"month":3,"riseRate":0.6,"avgChangeRate":0.157412},{"month":4,"riseRate":0.2,"avgChangeRate":-0.150119},{"month":5,"riseRate":0.6,"avgChangeRate":0.019748},{"month":6,"riseRate":0.4,"avgChangeRate":-0.03205},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.020452},{"month":8,"riseRate":0.5,"avgChangeRate":0.052764},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.071519},{"month":10,"riseRate":0,"avgChangeRate":-0.151349},{"month":11,"riseRate":0.666667,"avgChangeRate":0.098056},{"month":12,"riseRate":0.5,"avgChangeRate":0.047826}],"exchange":"NASDAQ","name":"Lantern Pharma Inc.","nameEN":"Lantern Pharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lantern Pharma Inc.(LTRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lantern Pharma Inc.(LTRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lantern Pharma Inc.,LTRN,Lantern Pharma Inc.股票,Lantern Pharma Inc.股票老虎,Lantern Pharma Inc.股票老虎国际,Lantern Pharma Inc.行情,Lantern Pharma Inc.股票行情,Lantern Pharma Inc.股价,Lantern Pharma Inc.股市,Lantern Pharma Inc.股票价格,Lantern Pharma Inc.股票交易,Lantern Pharma Inc.股票购买,Lantern Pharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lantern Pharma Inc.(LTRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lantern Pharma Inc.(LTRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}